trichloromethyl mercaptan | 75-70-7

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 卤代烷
• 英文名称: trichloromethyl mercaptan
• 英文别名: trichloromethanethiol；trichloromethanesulfenyl chloride；perchloromethanethiol；Trichlor-methanthiol；Trichlormethylmercaptan；perchloromethylmercaptan
• CAS: 75-70-7
• 化学式: CHCl₃S
• 分子量: 151.444
• InChiKey: ILSVYQNRDXIWLK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  5
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  trichloromethyl mercaptan 生成 alkaline earth salt of/the/ methylsulfuric acid
  参考文献：
  名称：

  176.硫代羰基四氯化物的组成和反应。第一部分与芳胺的反应

  摘要：

  DOI：

  10.1039/jr9340000822
• 作为产物：
  描述：

  四氯化碳 在 硫化氢 作用下， 生成 trichloromethyl mercaptan
  参考文献：
  名称：

  Avery; Forbes, Journal of the American Chemical Society, 1938, vol. 60, p. 1009

  摘要：

  DOI：
• 作为试剂：
  描述：

  4-Isobutyl-2,6-bis-trifluoromethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester 在 trichloromethyl mercaptan 、 lithium hexamethyldisilazane 作用下， 生成 Dimethyl 2,6-bis(trifluoromethyl)-3-chloro-3,4-dihydro-4-(2-methylpropyl)-3,5-pyridinedicarboxylate
  参考文献：
  名称：

  含氟吡啶二羧酸酯IV的衍生。N-取代的二氢吡啶衍生物†

  摘要：

  对于某些汉奇观察到的生物活性的衍生dihydropyridinecarboxylates含氟6,11和12和pyridinecarboxylates 10提示了若干有关的制备ñ -取代的二氢吡啶的第一次。一种方法涉及混合的Hantzsch序列，得到2，从中也分离并鉴定出意想不到的副产物3-5。第二种制备方法依靠的lithiobase去质子化6,11和12，接着通过烷基化或酰化，得到产品7-9和13-15。根据光谱特性和反应模式讨论了结构确定和立体分配。

  DOI：

  10.1002/jhet.5570270634

文献信息

• Oxazoles and their agricultural compositions
  申请人：Zeneca Limited

  公开号：US05705516A1

  公开（公告）日：1998-01-06

  A compound having the formula R--S(O).sub.n CH.sub.2 CH.sub.2 CH.dbd.CF.sub.2, wherein R is a phenyl group or a heterocyclic group selected from furyl, thienyl, isoxazolyl, isothiazolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 1,2,4-oxadiazolyl, 1,2,4-thiadiazolyl, 1,3,4-oxadiazolyl, 1,3,4-thidiazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl, 1,3,4-triazinyl, and 1,3,5-triazinyl groups, said phenyl or heterocyclic group being optionally substituted by optionally substituted alkyl, optionally substituted alkenyl, alkynyl, cycloalkyl, alkylcycloalkyl, alkoxy, alkenyloxy, alkynyloxy, hydroxyalkyl, alkoxyalkyl, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted aryloxy, optionally substituted arylalkoxy, optionally substituted aryloxyalkyl, optionally substituted heteroaryloxy, optionally substituted heteroarylalkoxy, optionally substituted heteroaryloxyalkyl, haloalkyl, haloalkenyl, haloalkynyl, haloalkoxy, haloalkenyloxy, haloalkynyloxy, halogen, hydroxy, cyano, nitro, --NR7R8, --NR7COR8, --NR7CSR8, --NR7SO2R8, --N(SO2R7)(SO2R8), --COR7, --CONR7R8, -alkylCONR7R8, --CR7NR8, --COOR7, --OCOR7, --SR7, --SOR7, --SO2R7, -alkylSR7, -alkylSOR7, -alkylSO2R7, --OSO2R7, --SO2NR7R8, --CSNR7R8, --SiR7R8R9, --OCH2CO2R7, --OCH2CH2CO2R7, --CONR7SO2R8, -alkylCONR7SO2R8, --NHCONR7R8, --NHCSNR7R8, or an adjacent pair of R1, R2, R3, R4, R5 and R6 when taken together form a fused 5- or 6-membered carbocyclic or heterocyclic ring; R7, R8 and R9 are each independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, alkynyl, optionally substituted aryl or optionally substituted arylalkyl, haloalkyl, haloalkenyl, haloalkynyl, halogen or hydroxy.

  具有化学式R--S(O).sub.n CH.sub.2 CH.sub.2 CH.dbd.CF.sub.2的化合物，其中R是苯基或从呋喃基，噻吩基，异噁唑基，异硫唑基，噁唑基，噻唑基，咪唑基，吡唑基，1,2,4-噁二唑基，1,2,4-硫二唑基，1,3,4-噁二唑基，1,3,4-硫二唑基，四唑基，吡啶基，吡啶嗪基，吡嗪基，1,2,3-三嗪基，1,3,4-三嗪基和1,3,5-三嗪基中选择的杂环基，所述苯基或杂环基可以选择地被可选择地取代的烷基，可选择地取代的烯烃基，炔基，环烷基，烷基环烷基，烷氧基，烯氧基，炔氧基，羟基烷基，烷氧基烷基，可选择地取代的芳基，可选择地取代的芳基烷基，可选择地取代的杂芳基，可选择地取代的杂芳基烷基，可选择地取代的芳氧基，可选择地取代的芳基氧基，可选择地取代的芳氧基烷基，可选择地取代的杂芳氧基，可选择地取代的杂芳基氧基烷基，卤代烷基，卤代烯烃基，卤代炔基，卤代烷氧基，卤代烯氧基，卤代炔氧基，卤素，羟基，氰基，硝基，--NR7R8，--NR7COR8，--NR7CSR8，--NR7SO2R8，--N(SO2R7)(SO2R8)，--COR7，--CONR7R8，-烷基CONR7R8，--CR7NR8，--COOR7，--OCOR7，--SR7，--SOR7，--SO2R7，-烷基SR7，-烷基SOR7，-烷基SO2R7，--OSO2R7，--SO2NR7R8，--CSNR7R8，--SiR7R8R9，--OCH2CO2R7，--OCH2CH2CO2R7，--CONR7SO2R8，-烷基CONR7SO2R8，--NHCONR7R8，--NHCSNR7R8，或R1，R2，R3，R4，R5和R6的相邻对一起形成融合的5-或6-成员碳环或杂环环时；R7，R8和R9分别独立地是氢，可选择地取代的烷基，可选择地取代的烯烃基，炔基，可选择地取代的芳基或可选择地取代的芳基烷基，卤代烷基，卤代烯烃基，卤代炔基，卤素或羟基。
• Diaryl substituted thiazoles useful in the treatment of fungal infections
  申请人：——

  公开号：US06156776A1

  公开（公告）日：2000-12-05

  Disclosed is a novel class of thiazole, thiadiazole, and oxadiazole compounds which are substituted at their nuclear carbons by aromatic moieties. These compounds exhibit antifungal activity against a variety of fungi including strains which have proven to be resistant to treatment with known antifungal agents such as Fluconazole.

  披露了一类新型的噻唑、噻二唑和噁二唑化合物，它们在核心碳上被芳香基取代。这些化合物对包括已被证明对已知抗真菌药物如氟康唑具有抗药性的各种真菌表现出抗真菌活性。
• Guanidino-heterocyclyl-phenyl-amidines and salts thereof
  申请人：Istituto de Angeli S.p.A.

  公开号：US04548944A1

  公开（公告）日：1985-10-22

  Compounds of the tautomeric formula ##STR1## wherein R, R.sub.1 and R.sub.2, which may be identical to or different from each other, are each hydrogen or alkyl of 1 to 4 carbon atoms; R.sub.3 is straight or branched alkyl, optionally interrupted by heteroatoms such as oxygen, sulfur or nitrogen; straight or branched alkenyl; alkynyl; cyano; cycloalkyl or cycloaliphatic alkyl; a bicyclic group; aryl; or a heterocyclic group; or R.sub.2 and R.sub.3, together with each other and the nitrogen atoms to which they are attached, form a heterocyclic group; R.sub.4 is hydrogen, halogen, alkyl of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; and Het is a substituted or unsubstituted heterocycle containing two or three heteroatoms; tautomers thereof, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as anti-ulcerogenics.

  具有互变式分子式##STR1##的化合物，其中R、R.sub.1和R.sub.2可以相同也可以不同，分别是氢或1至4个碳原子的烷基；R.sub.3是直链或支链烷基，可由氧、硫或氮等杂原子中断；直链或支链烯基；炔基；氰基；环烷基或环脂肪烷基；双环基团；芳基；或杂环基团；或R.sub.2和R.sub.3与彼此及它们连接的氮原子一起形成杂环基团；R.sub.4是氢、卤素、1至4个碳原子的烷基或1至4个碳原子的烷氧基；Het是含有两个或三个杂原子的取代或未取代杂环；其互变体，以及非毒性、药理学上可接受的酸盐。这些化合物及其盐可用作抗溃疡剂。
• Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors
  作者：Mitsunori Kono、Takahiro Matsumoto、Toru Kawamura、Atsushi Nishimura、Yoshihiro Kiyota、Hideyuki Oki、Junichi Miyazaki、Shigeru Igaki、Craig A. Behnke、Masato Shimojo、Masakuni Kori

  DOI：10.1016/j.bmc.2012.11.006

  日期：2013.1

  A series of piperazine ureas was designed, synthesized, and evaluated for their potential as novel orally available fatty acid amide hydrolase (FAAH) inhibitors that are therapeutically effective against pain. We carried out an optimization study of the lead compound 3 to improve its DMPK profile as well as in vitro potency. We identified the thiazole compound 60j with potent inhibitory activity, high

  设计，合成和评价了一系列哌嗪尿素作为新型口服可用的脂肪酸酰胺水解酶（FAAH）抑制剂的潜力，这些抑制剂可有效治疗疼痛。我们对前导化合物3进行了优化研究，以改善其DMPK谱以及体外效价。我们鉴定出噻唑化合物60j具有强抑制活性，高脑通透性和良好的生物利用度。化合物60j在小鼠的乙酸诱导的扭体试验中显示出强效且剂量依赖性的抗伤害感受作用。
• Synthetic Routes to, Transformations of, and Rather Surprising Stabilities of (<i>N</i>-Methyl-<i>N</i>-phenylcarbamoyl)sulfenyl Chloride, ((<i>N</i>-Methyl-<i>N</i>-phenylcarbamoyl)dithio)carbonyl Chloride, and Related Compounds
  作者：Alex M. Schrader、Alayne L. Schroll、George Barany

  DOI：10.1021/jo201329n

  日期：2011.10.7

  The title compound classes, (carbamoyl)sulfenyl chlorides and ((carbamoyl)dithio)carbonyl chlorides, have been implicated previously as unstable, albeit trappable, intermediates in organosulfur chemistry. The present work reports for each of these functional groups: (i) several routes to prepare it in the N-methylaniline family; (ii) its direct structural characterization by several spectroscopic techniques;

  先前已经将标题化合物类别（（氨基甲酰基）亚磺酰氯和（（氨基甲酰基）二硫代）羰基氯）认为是有机硫化学中不稳定的，尽管可捕集的中间体。本工作报告了这些官能团的每一个：（i）在N-甲基苯胺家族中制备它的几种途径；（ii）通过几种光谱技术对其结构进行直接表征；（iii）其相当意外的稳定性以及其分解时的最终命运；（iv）一系列进一步的化学转化，产生高度稳定的衍生物，每个衍生物都经过全面表征。进行了相关的动力学和机理实验，包括一些被对甲基和2,6-二甲基取代的N-甲基苯胺。鉴于标题化合物可以分离并且相对稳定，它们可以在制备用于半胱氨酸的巯基功能的硫解和/或光不稳定保护基中以及在开发新的蛋白质合成和修饰试剂中找到应用。